TheDose

Tetrasodium Edta

Also known as Tetrasodium edetate, EDTA tetrasodium salt, Edetate tetrasodium, Na4EDTA, Tetrasodium ethylenediaminetetraacetate

CIR

Safe

CIR Expert Panel says: safe as used in cosmetics.”

Tetrasodium EDTA (tetrasodium ethylenediaminetetraacetate; CAS 64-02-8; C10H12N2Na4O8) is the fully-neutralized tetrasodium salt of EDTA, used in cosmetic formulations at typical concentrations of 0.01–0.5% as a chelating agent to sequester divalent metal ions (Ca2+, Mg2+, Fe2+, Cu2+), improve formulation stability, prevent metal-catalyzed oxidation of actives and fragrances, and enhance the activity of antimicrobial preservatives. The Cosmetic Ingredient Review Expert Panel assessed EDTA and its salts as a group and concluded they are safe as used in cosmetic formulations, with the assessment published in Int J Toxicol 21(Suppl. 2):95-142, 2002. Tetrasodium EDTA has its own individual QRT row (Finding=S, no conditions or concentration cap), as do all the other EDTA salts reviewed in that group assessment (Disodium EDTA, Trisodium EDTA, Dipotassium EDTA, Tripotassium EDTA, TEA-EDTA, and EDTA itself). Tetrasodium EDTA is the fully-dissociated anion form at cosmetic pH ranges and, like other EDTA salts, is poorly absorbed through intact skin due to its high ionic polarity and large molecular weight.


Chelates divalent metal ions (Ca2+, Mg2+, Fe2+, Cu2+) to prevent metal-catalyzed oxidation of formulation components and improve stability

Enhances antimicrobial preservative efficacy by sequestering metal ions required for gram-negative bacterial outer-membrane integrity

Poorly absorbed through intact skin due to high ionic polarity (fully neutralized tetrasodium salt at cosmetic pH)

CIR Expert Panel concluded safe as used in cosmetic formulations as part of EDTA-salts group assessment:95-142, 2002); QRT row Finding=S with no conditions


CIR Expert Panel
Approved
[1]
CIR Expert Panel · Jul 1, 2018Live

CIR Quick Reference Table (12/2017, revised 07/2018) — Tetrasodium EDTA row: Finding=S (Safe), Citation=IJT 21(S2):95-142, 2002

Tetrasodium EDTA | S | [no detail column entry] | IJT 21(S2):95- 142, 2002QRT-122017revised072018.pdf, p. 133
Verificationpdf_textView source
Sources
1
PubMed citations
0
Evidence quality
limited
Last verified
Re-reviewed when a new CIR / SCCS opinion publishes.